Observation on the Clinical Effect of Needle Knife Release Combined with Microporous Decompression i

来源 :世界中西医结合杂志(英文版) | 被引量 : 0次 | 上传用户:chasel
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective: To observe the curative effect of release with needle knife combined with microporous decompression in bone marrow edema area of subchndral bone for treatment of knee osteoarthritis.Method: From March 2019 to March 2020, 66 patients with knee osteoarthritis were selected as the research objects, and divided into treatment group and control group according to random nuber table. The treatment group was treated with release with needle knife combined with microporous decompression in bone marrow edema area, while the control group was treated with release with needle knife. Visual analogue scale (VAS), the Western Ontario and McMaster University composite index (WOMCA) and inflammatory factors were used to evaluate the curative effect of patients before treatment and after treatment.Results: The VAS scores of knee pain in both groups decreased after treatment. The treatment group was lower than the control group. The WOMAC scores of both groups were decreased significantly after treatment, and then gradually decreased with time.The WOMAC scroes of the treatment group were lower than those of the control group after treatment,and there was an interactive effect on time factor. Conclusion: Release with needle knife combined with microporous decompression in bone marrow edema area of subchondral bone has good curative effect in the treatment of knee osteoarthritis; it can relieve the pain of patients, improve the function of joint, reduce inlfammatory reaction,and then delay the pathological progress of KOA,which is worthy of clinical promotion.
其他文献
国医大师刘志明教授,幼承庭训,正步杏林,从医80余载,在中医临床、科研、教学方面学验俱丰,临床疗效颇佳.文章从刘志明教授对桂枝加龙骨牡蛎汤的理解着笔,列举刘志明教授应用桂枝加龙骨牡蛎汤治疗遗精、汗证、心悸3则典型临床验案,以飨同道.
Objective: To systematically evaluate the efficacy and safety of Qidongyixin Oral Liquid (芪冬颐心口服液) in the treatment of coronary heart disease. Methods: Randomized controlled trials (RCTs) on the treatment of coronary heart disease (CHD) with Qidongyixin O
《伤寒论》麻子仁丸证,又称“脾约”证,是阳明病重要方证之一.它是阳明病燥热在发展过程中常常出现的一个证候,其病机为阳明燥热损伤太阴阴津,导致脾的转运功能失常而发生的津液偏渗现象,属于阳明病的虚实夹杂证,是阳明太阴同病,而实在阳明,虚在太阴,为实中夹虚.治疗脾约证应把好三环节:泻胃热、滋脾阴、润肠燥.麻子仁丸为阳明、太阴同治之方,方用小承气泻阳明之热,芍药滋太阴之阴,麻仁、杏仁润阳明与滋脾阴并施.并对方证所涉之“脾藏营”理论、厚朴用量、《伤寒论》趺阳诊法的内容及临床意义等进行了解读与研究.
Objective: To systematically evaluate and compare the effects of electro-acupuncture combined with biofeedback training and simple biofeedback training on the intervention of patients with functional defecation disorder.Methods: Computer retrieval was per
Objective: The purpose of this study is to systematicaly evaluate the safety of acupuncture in the treatment of chronic constipation in order to minimize clinical risk.Methods: The Cochrane database, MEDLINE, EMBASE, CBM, CNKI, VIP database and Wanfang da
灼口综合征(Burning mouth syndrome,BMS)是一种特发性疾病,临床病因病机复杂.李佃贵教授提出BMS浊毒致病论,浊毒内蕴是本病的病机关键.其认为BMS主要由饮食不节、情志不畅、邪毒伤络等损伤脾胃,脾胃不能运化水湿,湿浊久居不去,气滞、血瘀,日久化生浊毒,浊毒既是病理产物,又是致病因素,浊毒阻于舌体脉络而成.故以化浊解毒为治疗大法,贯穿始终,方从法出,并自拟灼口方治疗BMS,临床疗效显著.
Background: Depression will become the second most common disease after coronary heart disease (CHD). Escitalopram and olanzapine are commonly used to treat depression. Some studies indicated that escitalopram combined with olanzapine is effective in trea
Objective: To investigate the antihypertensive, antioxidant and renal protective effects of Eulcommia glycosides on renal hypertensive rats with two-kidney and one-clip type.Materials and Methods:A total of 50 healthy male SD rats were fed adaptive for on
Objective: This study conducted a systematic review of randomized controlled trials in order to evaluate the efficacy and safety of Baofukang Suppository (保妇康栓) combined with interferon on cervical high-risk human papillomavirus (HR-HPV) infection. Method
目的 研究抗癌痛方对通过胫骨内注射Walker 256细胞建立的癌症诱导性骨痛(CIBP)大鼠模型的抗伤害作用.方法 将96只4周龄SPF级雌性SD大鼠随机分成A组(16只)、B组(16只)、C组(64只).A组大鼠不做任何处理,B组大鼠左后腿胫骨注射无菌生理盐水15~20μl,C组大鼠左后腿胫骨注射肺癌细胞Walker 256建立CIBP模型.C组按照灌胃药物分为C1、C2、C3、C4组,每组16只.造模后14 d、15 d、16 d连续对C1组大鼠灌胃生理盐水(2 g/ml),C2组、C3组、C4组大